UCLA professor presented Chairman’s Award for “invaluable contributions” to American Heart Association goals, programs
Embargoed until 5 a.m. PT/8 a.m. ET, Monday, Nov. 13, 2017
ANAHEIM, California, Nov. 13 – The American Heart Association has presented its 2017 Chairman’s Award saluting excellence in volunteer service to Gregg C. Fonarow, M.D., of the University of California at Los Angeles, for “his many invaluable contributions to the Association’s strategic goals and programs while significantly advancing the science and practice of cardiology.”
Fonarow received the award Sunday during the opening of the American Heart Association Scientific Sessions 2017, a premier global exchange of the latest advances in cardiovascular science for researchers and clinicians, which was held at the Anaheim Convention Center. James J. Postl of Houston, Chairman of the Association’s national Board of Directors, presented the award, a citation and $1,000 honorarium. Fonarow is the Eliot Corday Professor of Cardiovascular Medicine and Science in UCLA’s David Geffen School of Medicine.
Presenting the award, Postl said, “Dr. Fonarow has provided exemplary leadership to the American Heart Association in numerous national and local roles.”
Those current roles include chairing the American Heart Association/American College of Cardiology Task Force on Performance Measures, AHA Workplace Health Steering Committee and AHA Get with the Guidelines Quality Improvement Subcommittee. He serves on numerous other Association committees and task forces, the chairman said.
“The personable Dr. Fonarow is recognized for being able to see ‘the wide vision’ or the ‘big picture’ and verbalize important details and their likely challenges,” Postl said. “He has also been essential to suggesting strategies to overcome these challenges and finding ways to address quality-of-care issues of cardiology today.”
For more news at AHA Scientific Sessions 2017, follow us on Twitter @HeartNews #AHA17.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.
About the American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.
For Media Inquiries and AHA Spokesperson Perspective:
AHA News Media in Dallas: 214-706-1173
AHA News Media Office, Nov. 11-15, 2017 at the Anaheim Convention Center: 714-765-2004
For Public Inquiries: 800-AHA-USA1 (242-8721)